Intravenous Zanamivir for Immunosuppressed Patients With Flu Intravenous Zanamivir for Immunosuppressed Patients With Flu

An intravenous formulation of a neuraminidase inhibitor is a good option for the treatment of influenza, especially for patients who cannot tolerate oral or inhaled treatments, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Related Links:

This study reports the case of a 6-year-old girl who complained of pain and curvature of the neck following an upper respiratory tract influenza infection. Notably, the patient`s neck pain and curvature worsened toward the end of her normal day for a week. This pattern is rare, but it represents an important example of Grisel`s syndrome as a condition that varies through the day. PMID: 32253881 [PubMed - in process]
Source: The Turkish Journal of Pediatrics - Category: Pediatrics Authors: Tags: Turk J Pediatr Source Type: research
Publication date: Available online 25 March 2020Source: Journal of Molecular BiologyAuthor(s): Christopher Swale, Bruno Da Costa, Laura Sedano, Frédéric Garzoni, Andrew A. McCarthy, Imre Berger, Christoph Bieniossek, Rob W.H. Ruigrok, Bernard Delmas, Thibaut Crépin
Source: Journal of Molecular Biology - Category: Molecular Biology Source Type: research
CONCLUSIONS: The season was delayed by sustained VRS circulation. The VE was lower than the national one. It is be essential to promote future campaigns to improve vaccination coverage. PMID: 32252987 [PubMed - as supplied by publisher]
Source: Medicina Clinica - Category: General Medicine Tags: Med Clin (Barc) Source Type: research
America ’s biopharmaceutical companies have joined forces to fight COVID-19. Armed with experience garnered from previous outbreaks and a vast storehouse of knowledge about infectious diseases like influenza, malaria and HIV, researchers are working to develop and deliver diagnostics, treatments and vacci nes to save lives and restore the rhythms of daily life for billions of people.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Coronavirus Source Type: news
Dr.Tracey McNamara on West Nile Fever and COVID-19   As interviewed by Edward Borton, GIDEON What was the experience of discovering a new virus outbreak on your doorstep? When New York City announced that people were dying of unusual encephalitis, I was struck by the timing and proximity between this event and an outbreak of crow deaths. Upon ruling out all known viruses that cause inflammation of the brain in birds, in the United States: exotic Newcastle, avian influenza, and Eastern Equine encephalitis (EEE), I knew this was something new. It wasn’t until I picked up the phone and called the U.S. Army and sai...
Source: GIDEON blog - Category: Databases & Libraries Authors: Tags: Epidemiology Events Outbreaks Tips Source Type: blogs
Authors: Kanyiri CW, Luboobi L, Kimathi M Abstract Influenza and pneumonia independently lead to high morbidity and mortality annually among the human population globally; however, a glaring fact is that influenza pneumonia coinfection is more vicious and it is a threat to public health. Emergence of antiviral resistance is a major impediment in the control of the coinfection. In this paper, a deterministic mathematical model illustrating the transmission dynamics of influenza pneumonia coinfection is formulated having incorporated antiviral resistance. Optimal control theory is then applied to investigate optimal ...
Source: Computational and Mathematical Methods in Medicine - Category: Statistics Tags: Comput Math Methods Med Source Type: research
(Wiley) The avian influenza virus subtype H16N3 is currently detectable in many countries. To examine the potential threat to humans of H16N3, researchers recently performed an extensive avian influenza surveillance in major wild bird gatherings across China from 2017-2019. The findings are published in Transboundary and Emerging Diseases.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
Publication date: Available online 6 April 2020Source: Antiviral ResearchAuthor(s): Saori Suzuki, Shintaro Shichinohe, Yasushi Itoh, Misako Nakayama, Hirohito Ishigaki, Yuya Mori, Ayako Ogata-Nakahara, Cong Thanh Nguyen, Masatoshi Okamatsu, Yoshihiro Sakoda, Hiroshi Kida, Kazumasa Ogasawara
Source: Antiviral Therapy - Category: Virology Source Type: research
Conditions:   Influenza;   Virus Intervention:   Sponsors:   Scripps Translational Science Institute;   CareEvolution Healthcare Technology Recruiting
Source: - Category: Research Source Type: clinical trials
The path to monetising influenza drug Avigan is littered with obstacles
Source: - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Health | Infectious Diseases | Influenza | Relenza | Zanamivir